Question 1

Does Loring Wolcott & Coolidge Fiduciary Advisors own IDXX stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Loring Wolcott & Coolidge Fiduciary Advisors holds 114,834 shares of IDXX (IDEXX Laboratories), worth $60M.

Question 2

How many shares of IDXX does Loring Wolcott & Coolidge Fiduciary Advisors own?

Accepted Answer

As of its Q3 2026 13F, Loring Wolcott & Coolidge Fiduciary Advisors holds 114,834 shares of IDXX (IDEXX Laboratories).

Question 3

What is Loring Wolcott & Coolidge Fiduciary Advisors' IDXX position worth?

Accepted Answer

As of its Q3 2026 13F, Loring Wolcott & Coolidge Fiduciary Advisors' IDXX position is worth $60M.

Question 4

Is Loring Wolcott & Coolidge Fiduciary Advisors buying or selling IDXX?

Accepted Answer

In Q3 2026, Loring Wolcott & Coolidge Fiduciary Advisors reduced its IDXX position by 2,361 shares (-2.0%).

Question 5

When did Loring Wolcott & Coolidge Fiduciary Advisors first buy IDXX?

Accepted Answer

Loring Wolcott & Coolidge Fiduciary Advisors already held IDXX in its Q1 2019 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	114,834	-2.0%	$60M	0.6%	$522.19	0
2026-Q2	Decreased	117,195	-4.2%	$61.7M	0.6%	$526.44	0
2026-Q1	Decreased	122,304	-1.4%	$68.9M	0.7%	$561.89	0
2025-Q4	Decreased	124,045	-2.4%	$86.2M	0.8%	$676.53	0
2025-Q3	Decreased	127,111	-3.5%	$81.2M	0.7%	$638.89	0
2025-Q2	Decreased	131,683	-1.6%	$70.6M	0.6%	$536.34	0
2025-Q1	Decreased	133,775	-0.5%	$57.1M	0.6%	$419.95	0
2024-Q4	Decreased	134,459	-0.3%	$57.5M	0.5%	$413.44	0
2024-Q3	Decreased	134,834	-3.1%	$61M	0.5%	$505.22	0
2024-Q2	Decreased	139,207	-0.8%	$69.5M	0.6%	$487.20	0
2024-Q1	Decreased	140,277	-1.1%	$67.3M	0.7%	$539.93	0
2023-Q4	Decreased	141,800	-5.7%	$73M	0.7%	$555.05	0
2023-Q3	Decreased	150,364	-2.8%	$63.1M	0.7%	$437.27	0
2023-Q2	Decreased	154,617	-0.1%	$77.7M	0.8%	$502.23	0
2023-Q1	Increased	154,716	+0.7%	$77.4M	0.9%	$500.08	42
2022-Q4	Increased	153,656	+0.4%	$62.7M	0.8%	$407.96	42
2022-Q3	Increased	153,079	+0.3%	$49.9M	0.6%	$325.80	41
2022-Q2	Increased	152,681	+0.4%	$53.5M	0.7%	$350.73	41
2022-Q1	Decreased	152,139	-0.2%	$83.2M	0.9%	$547.06	0
2021-Q4	Decreased	152,380	-1.1%	$100.3M	0.9%	$658.46	0
2021-Q3	Decreased	154,007	-0.1%	$95.8M	0.9%	$621.90	0
2021-Q2	Increased	154,200	+3.0%	$97.4M	1.0%	$631.55	43
2021-Q1	Increased	149,706	+1.3%	$73.3M	0.8%	$489.31	42
2020-Q4	Increased	147,837	+0.1%	$73.9M	0.8%	$499.87	42
2020-Q3	Decreased	147,635	-0.1%	$58M	0.7%	$393.11	0
2020-Q2	Decreased	147,752	-0.4%	$48.8M	0.7%	$330.16	0
2020-Q1	Increased	148,376	+1.3%	$35.9M	0.6%	$242.24	41
2019-Q4	Increased	146,549	+0.3%	$38.3M	0.5%	$261.13	41
2019-Q3	Decreased	146,084	-0.6%	$39.7M	0.6%	$271.93	0
2019-Q2	Decreased	146,925	-0.2%	$40.5M	0.6%	$275.33	0
2019-Q1	First report	147,235	-	$32.9M	0.5%	$223.60	0